September 24, 2013
Sanwa Kagaku Kenkyusho and Dainippon Sumitomo Pharma (DSP) have announced that the two companies will terminate a copromotion deal for the postprandial hyperglycemia treatment Seibule (miglitol) in March 2014. From April next year, Sanwa Kagaku will solely carry out detailing...read more